Basic Information
| LncRNA/CircRNA Name | EGOT |
| Synonyms | NA |
| Region | GRCh38_3:4749192-4751590 |
| Ensemble | ENSG00000235947 |
| Refseq | NR_004428 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qRT-PCR, Western blot |
| Sample | breast cancer tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | EGOT may inhibit breast cancer cell viability and migration via inactivation of the Hh pathway. |
| Pubmed ID | 32150666 |
| Year | 2020 |
| Title | LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway |
External Links
| Links for EGOT | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |